Novartis Pharmacuticals UK PA brief heads to APCO

APCO UK has won the public affairs brief for Novartis

Pharmaceuticals UK - as the Swiss drug giant prepares to roll out

several highly-anticipated new products.



The agency was awarded the brief after Novartis decided to beef up its

PA work.



Previously PA was handled by a small in-house team and a parliamentary

monitoring agency, but there was little emphasis on campaigning work,

said Novartis director of communications Jo Ashton.



She confirmed no pitch had been held. Instead APCO was picked on the

basis of work carried out for Ashton while she was working for her

previous employer, Lilly UK.



APCO, whose MD is Nick de Luca, will provide monitoring services as well

as strategic advice on products as they are launched.



Novartis retains eight other PR firms to promote individual

products.



Ashton said there were no plans to reduce the number of agencies.



Novartis is one of the largest suppliers of drugs to the NHS. Its

products include treatments for skin disease, cancer, cardiovascular

disease and schizophrenia.



The company was due to release annual results on 16 August and was

expected to post double-digit drug sales growth. Yet Novartis's

reputation for smoothly rolling out new products has been hit by delays

to the certification of two highly-anticipated new drugs; Zelmac/Zelnorm

for irritable bowel syndrome; and Xolair for asthma.



APCO is working on the launch of another product, Glivec, which treats

chronic myeloid leukemia. Glivec is to reach the market later this

year.



APCO's healthcare practice counts Eli Lilly UK, Thames Valley

Pharmaceuticals Group, Roche Products, the Multiple Sclerosis Society

and Macmillan Cancer Trust among its clients.



Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

Sky adds Fever PR to its roster after splitting with Cake

Sky adds Fever PR to its roster after splitting with Cake

Pay-TV giant Sky has added Fever PR to its agency line-up for a wide-ranging brief covering products and services.

Max Clifford trial jury to continue deliberations after Easter break

Max Clifford trial jury to continue deliberations after Easter break

The jury in the trial of celebrity publicist Max Clifford has been sent home for Easter and will reconvene on Tuesday for further deliberations about its verdicts on 11 charges of indecent assault.

Home Office brings in Munro & Forster to campaign against FGM

Home Office brings in Munro & Forster to campaign against FGM

The Home Office has tasked Munro & Forster (M&F) with supporting its campaign to eradicate female genital mutilation (FGM) as part of a wider retained brief.

Former White House press secretary Dee Dee Myers to join Warner Bros

Former White House press secretary Dee Dee Myers to join Warner Bros

Warner Bros has appointed former White House press secretary Dee Dee Myers as EVP for worldwide corporate communications and public affairs, effective September 2.